Celator Pharmaceuticals
Celator Pharmaceuticals researches and distributes therapies to treat cancer, leukemia and small cell lung cancer.
Business Model:
Revenue: $1
Employees: 11-50
Detailed Celator Pharmaceuticals Information
Celator Pharmaceuticals was acquired by
Jazz Pharmaceuticals.
The acquisition happend on 2016-05-31.
Details of the transaction were not public
Acquirer
Geographic Data
Address: 200 Princeton South Corporate Ctr
City: Ewing
State: NJ
Zip: 08628
Country: US
Financial Info
Stage:
debt financing
Raised Last:
$15M
Raised Total:$57M
Social
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Celator Pharmaceuticals researches and distributes therapies to treat cancer, leukemia and small cell lung cancer.
Contact Phone:
+16092430123
Contact Email:
Celator Pharmaceuticals went public on 9/13/2013 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
9/13/2013
Ticker Symbol:
CPXX
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
